SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GLAXOSMITHKLINE PHARMACEUTICAL

BSE: 500660 30 Sep 2025
Healthcare
₹ 2752
GlaxoSmithkline Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GLAXOSMITHKLINE PHARMACEUTICAL - Share Price & Details

Market Cap
₹45,272
High /Low
3,516 / 1,921
Stock P/E
47.8
Book Value
₹115.0
Dividend Yield
1.57
ROCE
63.2
ROE
₹46.9
Face Value
10.0
PEG Ratio
-2.44
EVEBITDA
₹32.4
Debt
9.95
CMP / FCF
59.1
Debt to equity
₹0.01
NP Ann
928
High price all time
3,516
Piotroski score
₹8.0
Graham Number
381.0
No. Eq. Shares
16.9
Net CF
₹475
Net profit
950
Price to book value
23.2
Interest Coverage
₹946.0
Low price all time
346.0
Industry PE
33.0
Reserves
₹1,782
Free Cash Flow
₹1,273

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
02 Sep 2025 Deven Choksey Buy ₹2,749.15 ₹2,300 -17.1% moneycontrol View
02 Aug 2025 Motilal Oswal Hold ₹2,933.9 ₹3,000 4.5% moneycontrol View
27 May 2025 ICICI Securities Sell ₹2,878.7 ₹2,600 -8% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
GLAXOSMITHKLINE PHARMACEUTICAL8485.92047.08048.312.0845,27247.8
Laurus Labs Limited14542.71579.414327.52.934493088.3
Narayana Hrudayalaya Limited9595.77873.719431.414.33525244.6

Peer Comparison Chart


About GLAXOSMITHKLINE PHARMACEUTICAL

GlaxoSmithkline Pharmaceuticals Ltd., with Security Code 500660, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Glaxosmithkline Pharmaceuticals Faces Market Evaluation Shift Amid Stabilizing Performance Metrics

(26 Sep 2025)
Glaxosmithkline Pharmaceuticals has recently adjusted its evaluation, indicating a shift in market position and technical indicators.
Read more →

Is Weakness In GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

(03 Sep 2025)
It is hard to get excited after looking at GlaxoSmithKline Pharmaceuticals' (NSE:GLAXO) recent performance, when its...
Read more →

GSK Pharma re-enters oncology market

(26 Aug 2025)
GlaxoSmithKline Pharma is re-entering the oncology market with the introduction of two advanced precision therapies for gynaecological...
Read more →

GSK Pharma forays into gynaecological cancer treatment in India

(25 Aug 2025)
GlaxoSmithKline Pharmaceuticals Ltd. stock zoomed as much as 2% on Monday, August 25. This movement in shares came after the company...
Read more →

GSK re-enters India’s cancer drug market

(25 Aug 2025)
GlaxoSmithKline Pharmaceuticals is re-entering India's oncology market with the launch of Jemperli and Zejula, precision therapies for...
Read more →

GSK Pharma Shares Up 1% on Entry Into Gynaecological Cancer Treatment in India

(25 Aug 2025)
Shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) rose 1% to touch a day's high of Rs 2,869 on 25th August, after the firm...
Read more →